Michael Milken
Diagnosed with advanced prostate cancer in 1993, the financier founded the Prostate Cancer Foundation, whose grants helped pay for the science behind abiraterone and enzalutamide and built a network of precision oncology centres for US veterans.
Overview
Michael Milken, the financier whose junk-bond career ended in a securities-fraud conviction, was diagnosed with advanced prostate cancer in 1993 and, as the Prostate Cancer Foundation's history records, founded the Foundation that year, transforming research, collaboration and awareness. PCF funds investigators and teams rather than running its own laboratories and insists on speed: short applications, fast decisions and a yearly retreat where grantees share unpublished data. Its own history credits $8 million of PCF funding toward the development of abiraterone (Zytiga) and $14.75 million toward enzalutamide (Xtandi), and a $65 million partnership with the US Department of Veterans Affairs in 2016 that established 22 precision oncology centres of excellence. Milken also founded FasterCures, part of the Milken Institute, to speed medical research more broadly.
Pages like this
not linked directly; found by shared links- PersonJon M. Huntsman Sr.
Shares Funding follows fashion, not burden and the tags hero, donor, patient.
- PersonMarc Lustgarten
Shares Funding follows fashion, not burden and the tags hero, donor, patient.
- PersonDebra Black
Shares Funding follows fashion, not burden and the tags hero, donor, patient.
- PersonSir Chris Hoy
Shares Prostate cancer and the tags hero, donor, patient.
- PersonRichard Rogel
Shares Funding follows fashion, not burden, Prostate cancer and the tags hero, donor.
- PersonJohn D. Rockefeller Jr.
Shares David H. Koch, Funding follows fashion, not burden and the tags hero, donor.
- PersonLarry Ellison
Shares The valley of death between lab and product, Funding follows fashion, not burden and the tags hero, donor.
- PersonAlfred P. Sloan Jr.
Shares The valley of death between lab and product, Funding follows fashion, not burden and the tags hero, donor.